検索結果

sion (CRAO), the therapeutic target of SJP-0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer sev...

sion (CRAO), the therapeutic target of SJP-0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer sev...

承認された治療法はありません でした 2,3。 参考文献 1 Boyer DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

The success of our premier line of ophthalmological drugs has launched our entry into other promising fields of medicine Senju Pharmaceutical greatly values the clinical experience of medical professi...

Production | About Senju | SENJU Pharmaceutical

test and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as injections, pharmaceutical technique standards and quality con...